{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:37:45Z","timestamp":1787585865409,"version":"build-2736575974"},"publisher-location":"Cham","reference-count":14,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319089263","type":"print"},{"value":"9783319089270","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T00:00:00Z","timestamp":1414627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T00:00:00Z","timestamp":1414627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-319-08927-0_9","type":"book-chapter","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T15:37:54Z","timestamp":1417534674000},"page":"59-65","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Molecular Genetics of Huntington\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Catherine","family":"Bobori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,30]]},"reference":[{"key":"9_CR1","unstructured":"Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical target in Huntington\u2019s disease. Department of Pharmacological Sciences and Centre for Stem Cell Research, Universita` degli Studi di Milano, Milan, Italy"},{"key":"9_CR2","doi-asserted-by":"crossref","unstructured":"Laforet GA, SappE, Chase K, McIntyre C, Boyce FM, Campbell M, Cadigan BA, Warzecki L, Tagle DA, Hemachandra Reddy P, Cepeda C, Calvert CR, Jokel ES, Klapstein GJ, Ariano MA, Levine MS, DiFiglia M, Aronin N, Changes in Cortical and Striatal Neurons Predict Behavioral and Electrophysiological Abnormalities in a Transgenic Murine Model of Huntington\u2019s Disease (2001) Departments of Psychiatry and Medicine, University of Massachusetts Medical School, Worcester, MA, Department of Neurology, Massachusetts General Hospital, Boston, MA, Genetics and Molecular Biology Branch, National Genome Research Institute, National Institutes of Health, Bethesda, MD, Mental Retardation Research Center, University of California at Los Angeles, Los Angeles, CA, and Department of Neuroscience, Chicago Medical School, North Chicago, IL, J Neurosci 21(23):9112\u20139123","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001"},{"key":"9_CR3","unstructured":"Maria Damiano, Laurie Galvan,Nicole Diglon, Emmanuel Brouillet, Mitochondria in Huntington's disease, Elsevier 11 August 2009"},{"key":"9_CR4","unstructured":"Mitochondria in Huntington\u2019s disease CEA, DSV, I2BM Molecular Imaging Research Center (MIRCen), CEA, CNRS URA 2210, F-92265 Fontenay-aux-Roses, France, 31 July 2009"},{"key":"9_CR5","doi-asserted-by":"crossref","unstructured":"Yamamoto A\u2020, Lucas JJ\u2020\u2021, Hen R (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease, Center for Neurobiology and Behavior Columbia University New York, New York, Cell, vol. 101, pp 57\u201366","DOI":"10.1016\/S0092-8674(00)80623-6"},{"key":"9_CR6","unstructured":"Cunha-Oliveira T, Ferreira IL, Cristina Rego A. Consequences of mitochondrial dysfunction in Huntington\u2019s disease and protection via phosphorylation pathways, CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Faculty of Medicine, University of Coimbra, Portugal"},{"key":"9_CR7","doi-asserted-by":"crossref","unstructured":"Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D (2006) Transcriptional repression of PGC-1a by mutant Huntingtin leads to mitochondrial dysfunction and neurodegeneration, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, MassGeneral Institute for Neurodegeneration, Charlestown, MA, USA, Department of Microbiology, New York University School of Medicine, New York, NY, Cell, vol 127, pp 59\u201369, Elsevier Inc.","DOI":"10.1016\/j.cell.2006.09.015"},{"key":"9_CR8","doi-asserted-by":"publisher","unstructured":"Mandemakers W, Morais VA, De Strooper B. A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases, Center for Human Genetics, K. U. Leuven and Department of Molecular and Developmental Genetics, VIB, Herestraat 49, 3000 Leuven, Belgium, Accepted 13 March 2007 J Cell Sci 120:1707\u20131716 Published by The Company of Biologists 2007 doi:10.1242\/jcs.03443","DOI":"10.1242\/jcs.03443"},{"issue":"10","key":"9_CR9","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1023\/A:1025682611389","volume":"28","author":"C Rego","year":"2003","unstructured":"Rego C, Oliveira CR (2003) Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases. Neurochem Res 28(10):1563\u20131574","journal-title":"Neurochem Res"},{"key":"9_CR10","unstructured":"Baron M, Kudin AP, Kunz WS (2007) Mitochondrial dysfunction in neurodegenerative disorders, Department of Epileptology and Life & Brain Center, University Bonn, Sigmund-Freud-Strasse 25, D-53105 Bonn, Germany, Biochemical Society Transactions, vol 35, part 5"},{"key":"9_CR11","doi-asserted-by":"crossref","unstructured":"Alexiou A, Psixa M, Vlamos P (2011) Ethnical issues of artificial biomedical applications, Department of Informatics, Ionian University, Corfu, Greece, Artificial Intelligence Applications and Innovations IFIP Advances in Information and Communication Technology, vol 364, pp 297\u2013302","DOI":"10.1007\/978-3-642-23960-1_36"},{"issue":"5","key":"9_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.6026\/97320630006173","volume":"6","author":"A Alexiou","year":"2011","unstructured":"Alexiou A, Rekkas J, Vlamos P (2011) Modeling the mitochondrial dysfunction in neurogenerative diseases due to high H+ concentration. Bioinformation 6(5):173\u2013175, PubMed: 21738307","journal-title":"Bioinformation"},{"key":"9_CR13","unstructured":"Alexiou A, Vlamos P (2012) Evidence for early identification of Alzheimer\u2019s disease. ArXiv:1209.4223v2 [q-bio.NC]"},{"key":"9_CR14","doi-asserted-by":"publisher","unstructured":"Alexiou A, Vlamos P (2012) A cultural algorithm for the representation of mitochondrial population, advances in artificial intelligence, vol. 2012, Hindawi Publishing, ID 457351, doi: 10.1155\/2012\/457351","DOI":"10.1155\/2012\/457351"}],"container-title":["Advances in Experimental Medicine and Biology","GeNeDis 2014"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-08927-0_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T12:28:40Z","timestamp":1675254520000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-08927-0_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,30]]},"ISBN":["9783319089263","9783319089270"],"references-count":14,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-08927-0_9","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,30]]},"assertion":[{"value":"30 October 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}